Page last updated: 2024-11-05

tolbutamide and Bright Disease

tolbutamide has been researched along with Bright Disease in 3 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kokot, F1
Kuska, J1
Spitz, I1
Rubenstein, AH1
Bersohn, I1
Lawrence, AM1
Kirsteins, L1

Other Studies

3 other studies available for tolbutamide and Bright Disease

ArticleYear
Clinicopathologic conference No. 121. Maculopapular rash and proteinuria.
    Postgraduate medicine, 1969, Volume: 45, Issue:2

    Topics: Aged; Diabetes Mellitus; Drug Hypersensitivity; Glomerulonephritis; Humans; Kidney; Male; Polyarteri

1969
[Insulin secretion in chronic kidney failure].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1973, Jun-15, Volume: 28, Issue:12

    Topics: Adolescent; Adult; Aged; Blood Glucose; Fatty Acids, Nonesterified; Female; Glomerulonephritis; Gluc

1973
The effect of dialysis on the carbohydrate intolerance of chronic renal failure.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1970, Volume: 2, Issue:2

    Topics: Adult; Blood; Blood Glucose; Carbon Dioxide; Depression, Chemical; Drug Tolerance; Fatty Acids, None

1970